| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/02/1999 | CA2321719A1 Farnesyl-protein transferase inhibitors |
| 09/02/1999 | CA2321667A1 Human channel-related molecules |
| 09/02/1999 | CA2321642A1 N-¬(substituted five-membered di- or triaza diunsaturated ring)carbonyl|guanidine derivatives for the treatment of ischemia |
| 09/02/1999 | CA2321178A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 09/02/1999 | CA2320289A1 Novel peptide copolymer compositions |
| 09/02/1999 | CA2319558A1 Injectable implants for tissue augmentation and restoration |
| 09/02/1999 | CA2319123A1 A pharmaceutical preparation comprising an angiotensin ii type 2 receptor agonist, and use thereof |
| 09/02/1999 | CA2318778A1 Method for decreasing qt dispersion or inhibiting the progression of qt dispersion with an angiotensin ii receptor antagonist |
| 09/01/1999 | EP0939124A2 MGBP1 sequences |
| 09/01/1999 | EP0939082A1 Protein polysaccharide 0041 |
| 09/01/1999 | EP0939077A2 3-Substituted 1-arylindole compounds as 5-HT2 antagonists |
| 09/01/1999 | EP0938560A1 GENOMIC NUCLEIC ACIDS, cDNA AND mRNA WHICH CODE FOR POLYPEPTIDES WITH IL-16 ACTIVITY, PROCESSES FOR THE PRODUCTION THEREOF AND THEIR USE |
| 09/01/1999 | EP0938554A1 Human protein kinase c inhibitor homolog |
| 09/01/1999 | EP0938494A1 Inhibitors of protein farnesyl transferase |
| 09/01/1999 | EP0938492A1 Combinatorial synthesis of carbohydrate libraries |
| 09/01/1999 | EP0938486A1 Substituted pyrrolopyrimidines and processes for their preparation |
| 09/01/1999 | EP0938482A1 5-substituted and 5,5-disubstituted-3,4-dihydroxy-2(5h)-furanones and methods of use therefor |
| 09/01/1999 | EP0938477A1 Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
| 09/01/1999 | EP0938476A1 Process for substituted pyridines |
| 09/01/1999 | EP0938471A1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 09/01/1999 | EP0938336A1 A method for enhancing long-term memory in a subject and uses thereof |
| 09/01/1999 | EP0938331A1 Therapeutic uses of bpi protein products in cystic fibrosis patients |
| 09/01/1999 | EP0938328A1 Method of inhibiting fibrosis with a somatostatin agonist |
| 09/01/1999 | EP0938309A1 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 09/01/1999 | EP0938304A1 Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants |
| 09/01/1999 | EP0723455A4 Methods of inhibiting phagocytosis |
| 09/01/1999 | EP0701616B1 Multicistronic expression of recombinant genes in bacterial cells |
| 09/01/1999 | EP0687267B1 Pyrrolo-pyridine derivatives as ligands of dopamine receptor |
| 09/01/1999 | EP0650475B1 4-amino-n-(4-methyl-4-piperidinyl)-2-methoxybenzamides, their preparation and their use as 5-ht2 antagonists |
| 09/01/1999 | EP0643780B2 Multiple solvent cleaning system |
| 09/01/1999 | CN1227563A Modified oligosaccharides |
| 09/01/1999 | CN1227560A Thienopyrimidines |
| 09/01/1999 | CN1227554A Substituted 6,5-hetero-bicyclic derivatives |
| 09/01/1999 | CN1227553A Bicyclic pyrimidine derivatives and their use as anti-coagulants |
| 09/01/1999 | CN1227552A Substituted pyrido- or pyrimido-containing 6,6- or 6,7-bicyclic derivatives |
| 09/01/1999 | CN1227550A Troponyl piperazines as selective dopamine D4 receptor ligands |
| 09/01/1999 | CN1227547A Arylalkanoyl pyridazines |
| 09/01/1999 | CN1227544A Tetrahydroquinoline derivatives as EAA antagonists |
| 09/01/1999 | CN1227543A Heterocyclylmethylamino derivatives of cyclobutene-3,4-diones as potassium channel modulators |
| 09/01/1999 | CN1227542A N-substituted indol-3-glyoxylamid with antiasthmatic, antiallergic and immunosuppressive/immunomodulating effect |
| 09/01/1999 | CN1227540A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 09/01/1999 | CN1227501A Long-acting drugs and pharmaceutical compositions comprising them |
| 09/01/1999 | CN1227497A Purified sperm surface antigen, monoclonal antibody therefor and application therefor |
| 09/01/1999 | CN1227496A Screening method for compounds useful in the regulation of body weight |
| 09/01/1999 | CN1227493A The use of heparin or heparan sulfate in combination with chitosan for prevention or treatment of infections caused by herpes virus |
| 09/01/1999 | CN1227491A Method for treating sinusitis with uridine triphosphates and related compounds |
| 09/01/1999 | CN1227489A Adenosine deaminase inhibitors |
| 09/01/1999 | CN1227487A Pharmaceutical compositions containing mesembrine and related compounds |
| 09/01/1999 | CN1227225A Thiazole derivatives |
| 09/01/1999 | CN1044912C Thio-substituted cyclic phosphonate compounds, and its pharmaceutical compositions and use |
| 09/01/1999 | CN1044911C Method for preparing prodrug |
| 09/01/1999 | CN1044910C Indole derivatives |
| 09/01/1999 | CN1044909C 吲哚衍生物 Indole derivatives |
| 09/01/1999 | CN1044897C Large potassium bicarbonate crystals and process for preparation thereof |
| 08/31/1999 | US5945566 Central nervous system |
| 08/31/1999 | US5945539 Enzyme inhibitor |
| 08/31/1999 | US5945513 A human t-cell antigen and ligand for cd40 receptor; for promoting b cell proliferation, immunosuppressant for transplants, therapy for autoimmune diseases, human immunodeficiency virus and antitumor agents |
| 08/31/1999 | US5945505 Human phospholemman-like protein |
| 08/31/1999 | US5945456 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
| 08/31/1999 | US5945446 Process for preparing synthetic soil-extract materials and medicaments based thereon |
| 08/31/1999 | US5945440 Indolocarbazole imides and the use thereof |
| 08/31/1999 | US5945439 Method for destroying or inhibiting growth of unwanted cells or tissues |
| 08/31/1999 | US5945426 Derivatives of pyrimidine for treating acute cerebrovascular disorders |
| 08/31/1999 | US5945403 Angiostatin fragments and method of use |
| 08/31/1999 | US5945398 In a hydrophilic carrier comprising propylene glycol,esterification product of vegetable oil triglyceride and polyalkalene glycol polyol and polyoxyethylene hydrogenated castor oil; free-flowing, clear, transparent |
| 08/31/1999 | US5945330 Polynucleotide |
| 08/31/1999 | US5945315 Isolating compound from culture of gsv224 nostoc species; antiproliferative agent for drug resistant cells |
| 08/31/1999 | US5945310 DNA encoding members of the IL-1 family, IL-1 delta |
| 08/31/1999 | US5945300 Polypeptides with dna(rna) encoding and genetic engineering |
| 08/31/1999 | US5945119 A plastic strip having microporous material impregnated with cesium chloride and magnesium sulfate on both side as antiarthritic agent or treatment of other soft tissue injuries; antiinflammatory agents |
| 08/31/1999 | US5944021 Therapeutic use of a carbonic anhydrase enzyme inhibitor for the treatment of brain edema |
| 08/31/1999 | CA2183315C Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 08/31/1999 | CA2183314C Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 08/31/1999 | CA2173328C Hiv protease inhibitors |
| 08/31/1999 | CA2145835C Hydroxamic acid derivatives with tricyclic substitution |
| 08/31/1999 | CA2118030C Drug for increasing the level of testosterone in the body |
| 08/31/1999 | CA2033447C Synergistic combination for treating herpes infections |
| 08/26/1999 | WO1999042602A2 Fermentative preparation process for cytostatics and crystal forms thereof |
| 08/26/1999 | WO1999042601A1 PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY |
| 08/26/1999 | WO1999042596A2 Phosphodiesterase 10 |
| 08/26/1999 | WO1999042579A2 Caf1-related protein |
| 08/26/1999 | WO1999042578A2 Modulation of cell proliferation, methods and reagents |
| 08/26/1999 | WO1999042577A2 Biotin-binding receptor molecules |
| 08/26/1999 | WO1999042573A1 Immunological methods to modulate myostatin in vertebrate subjects |
| 08/26/1999 | WO1999042568A1 Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
| 08/26/1999 | WO1999042562A1 NOVEL pgsA |
| 08/26/1999 | WO1999042485A1 Mucilage, a g-protein-coupled receptor |
| 08/26/1999 | WO1999042484A1 Fishboy, a g-protein coupled receptor |
| 08/26/1999 | WO1999042481A2 AGENTS FOR TREATING HUMAN ILLNESSES BASED ON β-CATENIN, AND THE PRODUCTION AND USE THEREOF |
| 08/26/1999 | WO1999042475A1 Azole peptidomimetics as thrombin receptor antagonists |
| 08/26/1999 | WO1999042470A1 Secreted proteins and polynucleotides encoding them |
| 08/26/1999 | WO1999042465A2 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 08/26/1999 | WO1999042458A1 Histamine h3 receptor ligands |
| 08/26/1999 | WO1999042456A2 Novel compounds and their use as positive ampa receptor modulators |
| 08/26/1999 | WO1999042453A1 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists |
| 08/26/1999 | WO1999042448A1 Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia |
| 08/26/1999 | WO1999042444A1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 08/26/1999 | WO1999042443A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
| 08/26/1999 | WO1999042436A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted-alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 08/26/1999 | WO1999042133A1 Inhibitors of complement activation |